Back to Market Feed

STEGLUJAN 5-100 MG TABLET

ertugliflozin and sitagliptin
$17.4091per EA

Strength

5; 100 mg/1; mg/1

NDC

00006536703

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/18/2025

Approval Type

New Drug (NDA)

FDA Application

NDA209805

On Market Since

12/19/2017

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.4%

3Y

-1.7%

5Y

-0.5%

All

-1.7%

Generic Alternatives

1 alternative • Same active ingredient

STEGLUJAN 5-100 MG TABLET
Brand
00006536706•Merck Sharp & Dohme LLC
$17.4091

Related Drugs

Same classification

ZITUVIMET XR 50-1,000 MG TABLET
Brand
70710180506•Zydus Pharmaceuticals (USA) Inc.
$5.0263
per EA
ZITUVIMET 50-1,000 MG TABLET
Brand
70710178706•Zydus Pharmaceuticals (USA) Inc.
$5.0308
per EA
ZITUVIMET 50-500 MG TABLET
Brand
70710178606•Zydus Pharmaceuticals (USA) Inc.
$5.0779
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008061•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008062•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008082•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057761•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057762•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057782•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET XR 50-500 MG TABLET
Brand
00006007861•Merck Sharp & Dohme LLC
$5.2815
per EA